{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T10:01:15Z","timestamp":1771063275285,"version":"3.50.1"},"reference-count":22,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T00:00:00Z","timestamp":1584144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Follicular lymphoma, the second most common non-Hodgkin lymphoma (NHL), primarily affects adults and shows an indolent clinical course. Rare cases of follicular lymphoma transform to a high-grade B-cell lymphoma with MYC and BCL2 rearrangements or \u201cdouble-hit lymphoma\u201d. Transformation to a \u201cdouble-hit lymphoma\u201d portends a worse prognosis and requires aggressive treatment. We report a comprehensive clinical, pathologic and radiographic review of a patient with previously undiagnosed low-grade follicular lymphoma that transformed into a \u201cdouble-hit lymphoma\u201d. The patient presented with a large heterogeneous mass 16 x 19 cm involving pancreatic head and neck and a mildly enlarged inguinal lymph node. Positron emission tomography (PET) study demonstrated Fluorodeoxyglucose (18F) (FDG)-avid peripancreatic mass. Tissue biopsy demonstrated a high-grade B-cell lymphoma with rearrangements t(14;18) and MYC, leading to the diagnosis of high-grade B-cell lymphoma with MYC and BCL2 rearrangements. Excisional biopsy of an inguinal lymph node demonstrated low-grade follicular lymphoma. Clonality studies demonstrated the same immunoglobulin clone V7-4 in inguinal lymph node and peripancreatic mass. Therefore, diagnosis of a high-grade B-cell lymphoma with MYC and BCL2 rearrangements that transformed from a low-grade follicular lymphoma was rendered. It is ultimately important to establish a tissue-based diagnosis at the different sites that are involved with lymphoma. Patient proceeded with the aggressive treatment with dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin and rituximab (EPOCH-R) treatment.<\/jats:p>","DOI":"10.3390\/diagnostics10030157","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T09:27:41Z","timestamp":1584437261000},"page":"157","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["High-grade B-cell Lymphoma with MYC and BCL2 Rearrangement Arising from Follicular Lymphoma: Presentation as a Large Peripancreatic Mass"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3471-5018","authenticated-orcid":false,"given":"Anna","family":"Shestakova","sequence":"first","affiliation":[{"name":"Department of Pathology, University of California, Irvine, CA 92868, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif","family":"Rezk","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California, Irvine, CA 92868, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dara","family":"Ghasemizadeh","sequence":"additional","affiliation":[{"name":"Department of Radiological Sciences, University of California, Irvine, CA 92868, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Nael","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California, Irvine, CA 92868, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California, Irvine, CA 92868, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2141.2012.09054.x","article-title":"Incidence, risk factors and outcome of histological transformation in follicular lymphoma","volume":"157","author":"Conconi","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1182\/blood-2010-05-282632","article-title":"Incidence of hematologic malignancies in Europe by morphologic subtype: Results of the HAEMACARE project","volume":"116","author":"Sant","year":"2010","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1002\/1097-0142(19821215)50:12<2699::AID-CNCR2820501202>3.0.CO;2-A","article-title":"Malignant lymphoma I. The histology and staging of 473 patients at the national cancer institute","volume":"50","author":"Anderson","year":"1982","journal-title":"Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e2017029","DOI":"10.4084\/mjhid.2017.029","article-title":"FDG-PET Scan: A New Paradigm for Follicular Lymphoma Management","volume":"9","author":"Gallamini","year":"2017","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_6","unstructured":"Swerdlow, S., Campo, E., Harris, N., Jaffe, E., Pileri, S., Stein, H., and Thiele, J. (2017). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, International Agency for Research on Cancer."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/sj.leu.2403738","article-title":"Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances","volume":"19","author":"Guo","year":"2005","journal-title":"Leukemia"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","article-title":"Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin\u2019s Lymphoma","volume":"26","author":"Gill","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1182\/blood-2015-01-621375","article-title":"Outcomes of transformed follicular lymphoma in the modern era: A report from the National LymphoCare Study (NLCS)","volume":"126","author":"Link","year":"2015","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.beha.2018.07.008","article-title":"An update in treating transformed lymphoma","volume":"31","author":"Godfrey","year":"2018","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/bjh.13463","article-title":"Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: A systematic review and meta-analysis","volume":"170","author":"Howlett","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V99.12.4265","article-title":"Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation","volume":"99","author":"Biagi","year":"2002","journal-title":"Blood"},{"key":"ref_14","first-page":"2975","article-title":"Nonrandom chromosome abnormalities in lymphoma","volume":"43","author":"Bloomfield","year":"1983","journal-title":"Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1200\/JCO.2015.65.7163","article-title":"Risk Factors and Outcomes for Patients with Follicular Lymphoma Who Had Histologic Transformation after Response to First-Line Immunochemotherapy in the PRIMA Trial","volume":"34","author":"Sarkozy","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1182\/blood-2010-03-272278","article-title":"Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones","volume":"116","author":"Eide","year":"2010","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","article-title":"Risk and Clinical Implications of Transformation of Follicular Lymphoma to Diffuse Large B-Cell Lymphoma","volume":"25","author":"Montoto","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Bischin, A.M., Dorer, R., and Aboulafia, D. (2017). Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma with MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review. Clin. Med. Insights Blood Disord., 10.","DOI":"10.1177\/1179545X17692544"},{"key":"ref_19","first-page":"619760","article-title":"Transformation of Follicular Lymphoma to Double Hit B-Cell Lymphoma Causing Hypercalcemia in a 69-Year-Old Female: A Case Report and Review of the Literature","volume":"2014","author":"Kapur","year":"2014","journal-title":"Case Rep. Hematol."},{"key":"ref_20","first-page":"788","article-title":"Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: Report of two cases and literature review","volume":"6","author":"Xu","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.beha.2011.02.006","article-title":"Transformation of follicular lymphoma","volume":"24","author":"Lossos","year":"2011","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.seminoncol.2014.08.006","article-title":"Postulated mechanisms of resistance of B-cell non-Hodgkin lymphoma to rituximab treatment regimens: Strategies to overcome resistance","volume":"41","author":"Bonavida","year":"2014","journal-title":"Semin. Oncol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/10\/3\/157\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:06:55Z","timestamp":1760173615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/10\/3\/157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,14]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["diagnostics10030157"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics10030157","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,14]]}}}